Neuronal grafts survive and are functional for many years in the brain;Transplanterade nervceller lever och fungerar i många år

Lakartidningen

Volumn 96, Issue 32-33, 1999, Pages 3407-3412

  Björklund, Anders ^a,c   Lindvall, Olle ^b  

^a Department of Histologi ^*  (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRAIN TRANSPLANTATION; CELL SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMAN; HUNTINGTON CHOREA; MEDICAL ETHICS; NERVE CELL; PARKINSON DISEASE; PHYSIOLOGY; REVIEW; SCINTISCANNING; SWINE; TIME; TRANSPLANTATION; ULTRASTRUCTURE; XENOGRAFT;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CELL SURVIVAL; CLINICAL TRIALS; ETHICS, MEDICAL; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; HUNTINGTON DISEASE; NEURONS; PARKINSON DISEASE; SWINE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033546576     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Björklund A. Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr Opin Neurobiol 1992; 2: 683-9.
2. Annett LE. Functional studies of neural grafts in Parkinsonian primates. In: Dunnett SB, Björklund A, eds. Functional neural transplantation. New York: Raven Press, 1994: 71-102.
3. Lindvall O. Neural transplantation: a hope for patients with Parkinson's disease. NeuroReport 1997; 8: iii-x.
4. Olanow CW, Freeman TB, Kordower JH. Neural transplantation as a therapy for Parkinson's disease. Adv Neurol 1997; 74: 249-69.
5. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJG, Mufson EJ, Sanberg PR et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995; 332: 1118-24.
6. Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 1998; 13: 383-93.
7. Lindvall O, Sawle G, Widner H, Rothwell JC, Björklund A, Brooks D et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994; 35: 172-80.
8. Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997; 42: 95-107.
9. Kordower JH, Styren S, Clarke M, DeKosky T, Olanow CW, Freeman TB. Fetal grafting for Parkinson's disease: Expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant 1997; 6: 213-9.
10. Othberg A, Keep M, Brundin P, Lindvall O. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro. Exp Neurol 1997; 147: 498-502.
11. Schierle GD, Hansson O, Leist M, Nicotera P, Widner H, Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 1999;5:97-100.
12. Rosenblad C, Martinez-Serrano A, Björklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 1996; 75: 979-85.
13. Studer L, Tabar V, McKay RDG. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nature Neuroscience 1998; 1: 290-5.
14. Deacon T, Schumacher J, Dinsmore J, Thomas C, Palmer P, Kott S et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997; 3: 350-3.
15. Sautter J, Tseng JL, Braguglia D, Sprenger C, Seiler RW, Widmer HR et al. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth and function of fetal dopaminergic grafts. Exp Neurol 1998; 149: 230-6.
16. Björklund A, Campbell K, Sirinathsinghji DJ, Fricker RA, Dunnett SB. Functional capacity of striatal transplants in the rat Huntington model. In: Dunnett SB, Björklund A, eds. Functional Neural Transplantation. New York: Raven Press, 1994: 157-95.
17. Kendall AL, Rayment FD, Torres EM, Baker HF, Ridley RM, Dunnett SB. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat Med 1998; 4: 727-9.
18. Palfi S, Condé F, Riche D, Brouillet E, Dautry C, Mittoux V et al. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat Med 1998; 4: 963-6.
19. Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K et al. Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD). Mov Disord 1996; 11: 143-50.
20. Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 1998; 149: 97-108